February 5, 2025 - 10:30

In a significant move to bolster its sustainability initiatives, Alfa Laval has acquired NRG Marine, a pioneer in ultrasonic anti-fouling technology. This acquisition marks a pivotal step for Alfa Laval as it seeks to enhance its portfolio of environmentally friendly solutions for the maritime industry.
NRG Marine's innovative technology addresses the persistent issue of biofouling on marine vessels, which not only impacts operational efficiency but also poses environmental challenges. By utilizing ultrasonic waves, the technology prevents the growth of marine organisms on ship hulls, thereby reducing the need for harmful anti-fouling paints and minimizing maintenance costs.
The integration of NRG Marine's capabilities aligns with Alfa Laval's commitment to promoting sustainable practices within the maritime sector. As the industry faces increasing pressure to reduce its environmental footprint, this acquisition positions Alfa Laval as a leader in providing solutions that support both operational efficiency and ecological responsibility. This strategic move is expected to drive growth and innovation in marine vessel maintenance.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...